financetom
Business
financetom
/
Business
/
Ryvyl, Roundtable Appoint Aly Madhavji as CFO Ahead of Merger
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ryvyl, Roundtable Appoint Aly Madhavji as CFO Ahead of Merger
Nov 6, 2025 9:53 AM

12:39 PM EST, 11/06/2025 (MT Newswires) -- Ryvyl ( RVYL ) and Roundtable said Thursday that Aly Madhavji will join the soon-to-be-merged company as chief financial officer.

As CFO, Madhavji will oversee financial strategy during the merger process and Nasdaq listing, the companies said, adding that current Ryvyl CFO George Oliva will transition to the role of chief accounting officer once the merger is complete.

In late September, Ryvyl ( RVYL ) said it agreed to merge with Roundtable in a $75 million deal, which is expected to close by the end of 2025, subject to shareholder approval and other closing conditions.

Upon completion, James Heckman will become chief executive officer, and Walton Comer will serve as chairman of a seven-member board. The merged company will be renamed RTB Digital and will operate under the Roundtable brand, the companies said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Intellia Therapeutics Says Drug Shows Potential in Phase 1 Transthyretin Amyloidosis Trial
Intellia Therapeutics Says Drug Shows Potential in Phase 1 Transthyretin Amyloidosis Trial
May 26, 2025
03:58 AM EDT, 05/19/2025 (MT Newswires) -- Intellia Therapeutics ( NTLA ) said Sunday it received positive two-year follow-up data from an ongoing phase 1 trial of its investigational drug nexiguran ziclumeran for the potential treatment of hereditary transthyretin amyloidosis with polyneuropathy, a genetic disease associated with the liver. The company said a one-time dose of the drug resulted in...
Nextracker Insider Sold Shares Worth $1,651,847, According to a Recent SEC Filing
Nextracker Insider Sold Shares Worth $1,651,847, According to a Recent SEC Filing
May 26, 2025
03:54 AM EDT, 05/19/2025 (MT Newswires) -- Bruce Ledesma, Chief Legal & Compliance Officer, on May 16, 2025, sold 27,453 shares in Nextracker ( NXT ) for $1,651,847. Following the Form 4 filing with the SEC, Ledesma has control over a total of 120,973 common shares of the company, with 120,973 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1852131/000095010325006146/xslF345X05/dp228973_4-ledesma.xml ...
SiTime Insider Sold Shares Worth $4,213,000, According to a Recent SEC Filing
SiTime Insider Sold Shares Worth $4,213,000, According to a Recent SEC Filing
May 26, 2025
03:56 AM EDT, 05/19/2025 (MT Newswires) -- Rajesh Vashist, Director, Chief Executive Officer, on May 16, 2025, sold 20,000 shares in SiTime ( SITM ) for $4,213,000. Following the Form 4 filing with the SEC, Vashist has control over a total of 518,719 common shares of the company, with 490,320 shares held directly and 28,399 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1451809/000133907625000003/xslF345X05/wk-form4_1747436833.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved